L. Selmeci

859 total citations
51 papers, 705 citations indexed

About

L. Selmeci is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Selmeci has authored 51 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Selmeci's work include Polyamine Metabolism and Applications (6 papers), Blood properties and coagulation (5 papers) and Nitric Oxide and Endothelin Effects (5 papers). L. Selmeci is often cited by papers focused on Polyamine Metabolism and Applications (6 papers), Blood properties and coagulation (5 papers) and Nitric Oxide and Endothelin Effects (5 papers). L. Selmeci collaborates with scholars based in Hungary, Denmark and Finland. L. Selmeci's co-authors include György Acsády, Leila Seres, Anikó Somogyi, Kàroly Rácz, Gábor Firneisz, Mária Székely, Zsolt Tulassay, Magda Antal, Andrea Regöly‐Mérei and Gabriella Lengyel and has published in prestigious journals such as PLoS ONE, Stroke and Biochemical and Biophysical Research Communications.

In The Last Decade

L. Selmeci

48 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Selmeci Hungary 14 174 148 123 122 103 51 705
Akira Suehiro Japan 14 90 0.5× 84 0.6× 112 0.9× 141 1.2× 110 1.1× 54 745
Shigeru TAKAMATSU Japan 14 166 1.0× 120 0.8× 193 1.6× 143 1.2× 125 1.2× 43 800
K. R. Bruckdorfer United Kingdom 14 196 1.1× 87 0.6× 111 0.9× 83 0.7× 102 1.0× 33 686
Lars Eikvar Norway 15 124 0.7× 108 0.7× 138 1.1× 162 1.3× 151 1.5× 26 655
Sayaka Arakawa Japan 11 183 1.1× 77 0.5× 70 0.6× 139 1.1× 59 0.6× 36 731
Jocelyne Bidault France 16 198 1.1× 110 0.7× 82 0.7× 109 0.9× 57 0.6× 28 884
Hye Kyoung Song South Korea 17 213 1.2× 191 1.3× 144 1.2× 133 1.1× 254 2.5× 19 894
Michiko Asano Japan 17 252 1.4× 200 1.4× 212 1.7× 89 0.7× 112 1.1× 51 887
Hiroki Tsuchida Japan 17 336 1.9× 145 1.0× 133 1.1× 115 0.9× 51 0.5× 47 923
Takayuki Sasahara Japan 13 179 1.0× 328 2.2× 198 1.6× 174 1.4× 73 0.7× 22 1.1k

Countries citing papers authored by L. Selmeci

Since Specialization
Citations

This map shows the geographic impact of L. Selmeci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Selmeci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Selmeci more than expected).

Fields of papers citing papers by L. Selmeci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Selmeci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Selmeci. The network helps show where L. Selmeci may publish in the future.

Co-authorship network of co-authors of L. Selmeci

This figure shows the co-authorship network connecting the top 25 collaborators of L. Selmeci. A scholar is included among the top collaborators of L. Selmeci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Selmeci. L. Selmeci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somogyi, Anikó, et al.. (2011). Higher Serum DPP-4 Enzyme Activity and Decreased Lymphocyte CD26 Expression in Type 1 Diabetes. Pathology & Oncology Research. 17(4). 925–930. 44 indexed citations
3.
Firneisz, Gábor, Gabriella Lengyel, János Fehér, et al.. (2010). Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker. PLoS ONE. 5(8). e12226–e12226. 105 indexed citations
4.
Selmeci, L., et al.. (2005). Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique. Clinical Chemistry and Laboratory Medicine (CCLM). 43(3). 294–7. 71 indexed citations
5.
Seres, Leila, Pál Soós, Mária Székely, Ferenc Horkay, & L. Selmeci. (2004). Antioxidant capacity of the human pericardial fluid: does gender have a role?. Clinical Chemistry and Laboratory Medicine (CCLM). 42(8). 952–7.
6.
Székely, Mária, et al.. (2003). Impairment of Blood-Brain Barrier Integrity during Carotid Surgery as Assessed by Serum S-100B Protein Concentrations. Clinical Chemistry and Laboratory Medicine (CCLM). 41(10). 1320–2. 17 indexed citations
7.
Nagy, Gabriella, et al.. (2002). Biochemical Alterations in Cerebrospinal Fluid During Thoracoabdominal Aortic Cross-clamping in Dogs. Annals of Vascular Surgery. 16(4). 436–441. 11 indexed citations
8.
Selmeci, L., Magda Antal, Ferenc Horkay, et al.. (2000). Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease. Coronary Artery Disease. 11(1). 53–56. 18 indexed citations
9.
Szabó, Tamás, László Gellér, Béla Merkely, et al.. (2000). Investigating the dual nature of endothelin-1: Ischemia or direct arrhythmogenic effect?. Life Sciences. 66(26). 2527–2541. 26 indexed citations
10.
Szokodi, István, Ferenc Horkay, L. Selmeci, et al.. (1998). Characterization of Canine Pericardial Fluid Endothelin-1 Levels. Journal of Cardiovascular Pharmacology. 31. S399–S400. 6 indexed citations
11.
Horkay, Ferenc, István Szokodi, Rudolf deChâtel, et al.. (1998). High Pericardial Fluid Levels of Endothelin Are Not Caused by Altered Neutral Endopeptidase Activity in Cardiac Patients. Journal of Cardiovascular Pharmacology. 31. S287–S289. 4 indexed citations
12.
Horkay, Ferenc, István Szokodi, Béla Merkely, et al.. (1998). Potential Pathophysiologic Role of Endothelin-1 in Canine Pericardial Fluid. Journal of Cardiovascular Pharmacology. 31. S401–S402. 7 indexed citations
13.
Horkay, Ferenc, István Szokodi, L. Selmeci, et al.. (1997). PRESENCE OF IMMUNOREACTIVE ENDOTHELIN-1 AND ATRIAL NATRIURETIC PEPTIDE IN HUMAN PERICARDIAL FLUID. Life Sciences. 62(3). 267–274. 24 indexed citations
14.
Selmeci, L., et al.. (1994). Altered polyamine levels in skeletal muscle of patients with myasthenia gravis.. PubMed. 13(4). 181–4. 9 indexed citations
15.
Kecskeméti, Valéria, et al.. (1987). Modification of the cardiac transmembrane potentials and currents by polyamines. European Journal of Pharmacology. 142(2). 297–303. 6 indexed citations
16.
Kecskeméti, Valéria, et al.. (1987). Modification of cardiac transmembrane potentials and currents by polyamines. Journal of Molecular and Cellular Cardiology. 19. S42–S42. 1 indexed citations
17.
Kremmer, T., et al.. (1984). Polyamine Metabolism in P388 Leukemia Cells and in Ascites Tumor-Bearing Mice. Pathobiology. 52(5). 279–285. 2 indexed citations
18.
Selmeci, L., et al.. (1979). Hypertrophic response of the kidney in indomethacin treated rats.. PubMed. 53(4). 427–32. 1 indexed citations
19.
Selmeci, L. & E. Pósch. (1971). The effect of NADH and NAD+ on the proteolysis of lactate dehydrogenase isozymes by trypsin. Cellular and Molecular Life Sciences. 27(8). 888–889. 4 indexed citations
20.
Selmeci, L., et al.. (1967). The effect of hypoxia on the lactic dehydrogenase /LDH/ activity of serum and heart muscle of rats. Life Sciences. 6(6). 649–653. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026